[at noodls] – NEW YORK, NY – November 06, 2012 — Delcath Systems, Inc. (NASDAQ: DCTH) announced today that executive management will present at the Lazard Capital Markets Healthcare Conference on Tuesday, November … moreView todays social media effects on DCTHView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – DELCATH RECEIVES REGULATORY APPROVAL FOR THE GENERATION TWO HEPATIC CHEMOSAT® DELIVERY SYSTEM IN AUSTRALIA NEW YORK, NY – November 5, 2012 – Delcath Systems, Inc. (NASDAQ: DCTH) today announced the Therapeutic … moreView todays social media effects on DCTHView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – NEW YORK, October 26, 2012 — Delcath Systems, Inc. (Nasdaq: DCTH) announced today that it will host a conference call and webcast on Wednesday, November 7, 2012 at 4:30 p.m. ET to discuss its financial … moreView todays social media effects on DCTHView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – Provides Basis for Regulatory Applications in Key Asian Markets New York, Oct 22, 2012 – (ACN Newswire) – Delcath Systems, Inc. (NASDAQ: DCTH) today announced that the Company has satisfied all of the … moreView todays social media effects on DCTHView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingAfter much anticipation over the last few weeks, Delcath Systems (NASDAQ:DCTH) announced Monday that the New Drug Application for its CHEMOSAT hepatic chemosaturation system has been accepted … moreView todays social media effects on DCTHView the latest stocks trending across Twitter. Click to view dashboard […]
